IREN director records share grant and prior sale
IREN Ltd director Christopher Guzowski reported a mix of equity compensation and prior share sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IREN Ltd director Christopher Guzowski reported a mix of equity compensation and prior share sales. He received 6,657 Ordinary Shares on July 1, 2026 as a grant of restricted stock units, at a stated price of $0.00 per share, which will vest only if specified conditions are met.
The filing also reports an earlier open-market sale on September 16, 2025 of 11,958 Ordinary Shares at $36.32 per share. Following the most recent grant, Guzowski directly holds 45,825 Ordinary Shares of IREN Ltd.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Ordinary Shares | 6,657 | $0.00 | $0.00 |
| Sale | Ordinary Shares | 11,958 | $36.32 | $434K |
Footnotes (1)
- F1. Represents a grant of restricted stock units that will vest subject to the Reporting Person's satisfaction of applicable vesting conditions.
Key Figures
Key Terms
restricted stock units financial
open-market sale financial
grant, award, or other acquisition financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did IREN (IREN) director Christopher Guzowski report?
AI-generated analysis. How Rhea-AI works. Not financial advice.